Asylia Diagnostics Company
Asylia Diagnostics - precision medicine data platform for immunotherapies
Total Funding:
1100000.0
Headquarters:
Delaware City, Delaware, United States
Funding Status:
Seed
Employee Number:
45200
Estimated Revenue:
Less than $1M
Last Funding Type:
Series B
Technology:
['BioTech & HealthTech']
Investor Type:
andrey.khmelevskiy@asyliadx.com
Last Funding Date:
2020-03-02
Investors Number:
2.0
Founded Date:
2019-08-22
Industry:
Medical BioTech